 Icon NASDAQ:ICLR was upgraded by Zacks Investment Research from a sell rating to a hold rating in a report released on Thursday, Zacks.com reports. According to Zacks, ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. Several other research analysts have ... 